摘要
目前,心血管疾病是发达国家人口的第一死亡原因。至2020年,心血管疾病也将成为发展中国家的首位死因。冠心病是最常见的心血管疾病,死亡率和致残率高,其中非ST段抬高型急性冠脉综合征(NSTEACS)较ST段抬高型心肌梗死(STEMI)更为常见。
出处
《国际心血管病杂志》
2011年第6期321-325,共5页
International Journal of Cardiovascular Disease
参考文献12
-
1Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarc- tion) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovas- cular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine[J]. J Am Coll Cardiol,2007, 50(7) :el e157.
-
2Task Force for Diagnosis and Treatment of Non-ST Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes[J]. Eur Heart J, 2007, 28(13) 1598- 1660.
-
3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2136
-
4Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/ AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physi-cians, Society for Cardiovascular Angiography and Interven- tions, and Society of Thoracic Surgeons [J]. J Am Coll Cardiol,2011,57(19) : 1920-1959.
-
5Authors/Task Force Members, Hamm CW, Bassand JP, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-seg- ment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J,2011,Sep 21. [Epub ahead of print].
-
6经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-25. 被引量:544
-
7Dixon SR, Grines CL, O'neill WW. The year in interven- tional cardiology[J]. J Am Coil Cardiol, 2010, 55(20): 2272 -2286.
-
8Fox KA, Clayton TC, Damman P, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non ST segment elevation acute coronary syndrome a meta- analysis of individual patient data[J]. J Am Coil Cardiol, 2010,55(22) :435- 445.
-
9Sorajja P, Gersh BJ, Cox DA, et al. Impact of delay to an- gioplasty in patients with acute coronary syndromes under- going invasive management. Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Stra- tegy) trial[J]. J Am Coil Cardiol 2010~55(14): 1416-1424.
-
10Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes[J]. N Engl J Med, 2009, 360(21): 2165-2175.
二级参考文献27
-
1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
-
2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
-
3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
-
4Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
-
5Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
-
6Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
-
7CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
-
8Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
-
9Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
-
10Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
共引文献2661
-
1毕颖斐,王贤良,赵志强,侯雅竹,毛静远,张伯礼.冠心病中医证候地域性特征的临床流行病学调查[J].中医杂志,2020,61(5):418-422. 被引量:62
-
2王宇杰,杨振刚,蒋文潇,郭佳丽,杨科,陶均英,许轶洲,童国新,周仕平.温阳化饮方对不稳定型心绞痛阳虚饮停证患者冠状动脉血运重建后反复心绞痛发作的影响[J].中医杂志,2020,0(3):226-228. 被引量:10
-
3赵中松,葛树龙,孙萍,牛洪梅,段淑香,孟海燕,孟晓萍.经穴体外反搏治疗不稳定型心绞痛的临床效果[J].慢性病学杂志,2022(10):1461-1463. 被引量:1
-
4赵乾,李宇林,郭俊林,庹田.冠心病患者血清Ghrelin、SUA、MPV表达及与PCI后不良心血管事件关系[J].慢性病学杂志,2022(4):560-562. 被引量:1
-
5谭丽.联合用药对冠心病心绞痛临床疗效的影响[J].慢性病学杂志,2021(8):1253-1254. 被引量:2
-
6许彩,刘婷.不同用药方案治疗老年冠心病不稳定型心绞痛患者临床疗效[J].慢性病学杂志,2021(8):1248-1249. 被引量:2
-
7张美玲,穆托航,文国顺.桃红通痹汤联合西药治疗不稳定型心绞痛的临床效果[J].慢性病学杂志,2021(8):1223-1225. 被引量:1
-
8刘展.延续性护理对冠心病介入治疗患者疾病认知及自我管理水平的影响[J].慢性病学杂志,2019,0(10):1508-1509. 被引量:3
-
9张雪桦.中医辨证理疗联合耳穴压豆对改善不稳定型心绞痛患者心功能的影响[J].心血管病防治知识(学术版),2022,12(10):20-22. 被引量:5
-
10王美玲.阿司匹林、替格瑞洛联合应用在不稳定型心绞痛治疗中的效果观察[J].心血管病防治知识(学术版),2020(16):29-31. 被引量:2
同被引文献46
-
1李芳,余素琴,王琳.替罗非班对急性冠状动脉综合征患者临床症状和心电图的影响[J].临床心血管病杂志,2004,20(8):466-467. 被引量:23
-
2李建军.他汀类药物治疗急性冠脉综合症的抗炎机制[J].临床内科杂志,2006,23(1):8-11. 被引量:20
-
3宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
-
4严金川,马根山,冯毅,沈成兴,戴启明,朱建.国产替罗非班治疗急性冠状动脉综合征的安全性和有效性[J].中国介入心脏病学杂志,2007,15(2):96-98. 被引量:32
-
5韦信安.阿司匹林+低分子肝素治疗非ST段抬高急性冠脉综合征基础上加用氯吡格雷疗效观察[J].健康必读:下月刊,2011(7):343.
-
6Hermanides RS, Ottervanger JP,ten Berg JM,et al.Net clin- ical benefit of prehospital glycoprotein I1 b/lll a inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding:effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score [J].J In- vasive Cardiol, 2012,24 (3) : 84-89.
-
7Guo J, Xu M, Xi Y.Tirofiban-indueed diffuse alveolar hem- orrhage:after primary angioplasty[J].Tex Heart Inst J,2012, 39(1) :99-103.
-
8Lang SH,Manning N,Armstrong N,et al.Treatment with tirofiban for acute coronary syndrome (ACS):a systematic re- view and network analysis[J].Curr Med Res Opin,2012,28 (3) :351-370.
-
9张玉芝,赵玉兰.奥扎格雷钠治疗非ST段抬高急性冠状动脉综合征[J].中原医刊,2008,35(8):84-85. 被引量:1
-
10杨志美.非ST段抬高急性冠脉综合征的药物治疗[J].基层医学论坛,2009,13(8):261-262. 被引量:4
引证文献5
-
1陈静波.盐酸替罗非班治疗非ST段抬高急性冠脉综合征的疗效与安全性[J].中国医学工程,2013,21(2):174-175. 被引量:5
-
2王丽君.非ST段抬高急性冠脉综合征治疗策略(综述)[J].中国城乡企业卫生,2013,28(2):63-65. 被引量:1
-
3潘唐超,梁松,卢梓添.急诊早期应用替罗非班辅助治疗非ST段抬高性急性冠脉综合征的效果和安全性[J].中国当代医药,2014,21(20):92-94.
-
4罗显洪,夏豪,唐东梁,余太辉.溶血磷脂酸对于评估不稳定心绞痛患者不良预后的临床意义[J].安徽医药,2015,19(9):1704-1708. 被引量:1
-
5谢星星,张杰,范小冬,刘易陇,黄飞鸿,余彬,范玲.磺达肝癸钠治疗中国非ST段抬高急性冠状动脉综合征疗效与安全性的系统评价[J].中国药房,2022,33(7):879-884. 被引量:1
二级引证文献8
-
1杜秋芬.血府逐瘀汤治疗非ST段抬高型急性冠脉综合征的临床研究[J].心血管病防治知识(学术版),2013,3(12):89-91. 被引量:1
-
2吴志红,孙玉然,丁秋蕾,连晓芳,王香玲,任岩春,都伟,王云英,安少波,徐雷.小剂量替罗非班在老年非ST段抬高型ACS中的应用[J].临床心血管病杂志,2014,30(1):31-34. 被引量:14
-
3陈平钰,马爱霞.急性冠脉综合征药物干预策略经济学评析综述[J].中国药物评价,2014,31(3):189-192. 被引量:2
-
4刘建峰,朱莹,王晓玮,刘丽宏.国产替罗非班对中国人群非ST段抬高急性冠脉综合征有效性与安全性的Meta分析[J].中国循证医学杂志,2015,15(1):90-98. 被引量:16
-
5袁青山,将龙元,周天恩.急性冠状动脉综合征老年患者院前急救应用替罗非班的有效性及安全性[J].中国当代医药,2016,23(1):45-47. 被引量:4
-
6孟亚锋,范春雨,刘锦.盐酸替罗非班治疗非ST段抬高型ACS的系统评价[J].中西医结合心脑血管病杂志,2016,14(11):1266-1269. 被引量:9
-
7孙健,温澄非,关蓬,张磊.舒血宁联合瑞舒伐他汀治疗急性心肌梗死伴心绞痛临床评价[J].中国药业,2019,28(9):56-58. 被引量:5
-
8吴琪,季梅丽,张蓉,王丹蕾,夏佩佩.老年不稳定心绞痛及伴有衰弱患者皮下注射低分子肝素后出血的危险因素分析[J].国际老年医学杂志,2024,45(2):147-151.
-
1孟亚锋,范春雨,刘锦.盐酸替罗非班治疗非ST段抬高型ACS的系统评价[J].中西医结合心脑血管病杂志,2016,14(11):1266-1269. 被引量:9
-
2陈伟泉.替格瑞洛对于伴发糖尿病的ST段抬高型急性冠脉综合征的患者心肌保护作用分析[J].临床和实验医学杂志,2016,15(13):1281-1284. 被引量:10
-
3曹静.106例急性冠脉综合征的治疗体会[J].实用医技杂志,2007,14(7Z):2748-2749.
-
4贾随明.麝香保心丸治疗非ST段抬高型急性冠脉综合征23例[J].中西医结合心脑血管病杂志,2014,12(10):1204-1205. 被引量:4
-
5张舒,史平,马麟.丹参川芎嗪对改善非ST段抬高型急性冠脉综合征(中低危组)临床症状的评价[J].中国实用医药,2014,9(25):143-145. 被引量:3
-
6胡琴,吕玉兰.急性冠脉综合征46例诊断经验总结[J].中国当代医药,2010,17(11):127-127. 被引量:3
-
7赵连明,张玉,杜明.低分子肝素治疗无ST段抬高型急性冠脉综合征54例疗效观察[J].山东医药,2003,43(1):47-48.
-
8孙静,周立平,刘允桂,孙明喜,巴静.血清尿酸和C-反应蛋白水平与冠心病关系的探讨[J].中国实验诊断学,2008,12(4):501-502. 被引量:1
-
9李建军.炎症可能是高血压致动脉粥样硬化的重要机制[J].中国循环杂志,2007,22(2):157-158. 被引量:6
-
10李晓云,董颀,陈敏生.替格瑞洛对ST段抬高型急性冠脉综合征合并糖尿病患者的心肌保护作用[J].广东医学,2015,36(8):1257-1260. 被引量:16